Xu L - Search Results

1

Mining Symptom-Herb Patterns from Patient Records Using Tripartite Graph.

Chen J, Poon J, Poon SK, Xu L, Sze DM. Chen J, et al. Among authors: xu l. Evid Based Complement Alternat Med. 2015;2015:435085. doi: 10.1155/2015/435085. Epub 2015 Jun 8. Evid Based Complement Alternat Med. 2015. PMID: 26167191 Free PMC article.

2

Lessons learnt from evidence-based approach of using chinese herbal medicines in liver cancer.

Zheng Z, Cho WC, Xu L, Wang J, Sze DM. Zheng Z, et al. Among authors: xu l. Evid Based Complement Alternat Med. 2013;2013:656351. doi: 10.1155/2013/656351. Epub 2013 May 29. Evid Based Complement Alternat Med. 2013. PMID: 23818930 Free PMC article.

3

Application of genetic algorithm for discovery of core effective formulae in TCM clinical data.

Yang M, Poon J, Wang S, Jiao L, Poon S, Cui L, Chen P, Sze DM, Xu L. Yang M, et al. Among authors: xu l. Comput Math Methods Med. 2013;2013:971272. doi: 10.1155/2013/971272. Epub 2013 Oct 30. Comput Math Methods Med. 2013. PMID: 24288577 Free PMC article.

4

Bufalin Reverses HGF-Induced Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer Cells via Blockage of Met/PI3k/Akt Pathway and Induction of Apoptosis.

Kang XH, Xu ZY, Gong YB, Wang LF, Wang ZQ, Xu L, Cao F, Liao MJ. Kang XH, et al. Among authors: xu l, xu zy. Evid Based Complement Alternat Med. 2013;2013:243859. doi: 10.1155/2013/243859. Epub 2013 Feb 28. Evid Based Complement Alternat Med. 2013. PMID: 23533466 Free PMC article.

5

Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5--Fluorouracil in CT26 colon carcinoma.

Deng S, Hu B, An HM, Du Q, Xu L, Shen KP, Shi XF, Wei MM, Wu Y. Deng S, et al. Among authors: xu l. BMC Complement Altern Med. 2013 Jun 8;13:128. doi: 10.1186/1472-6882-13-128. BMC Complement Altern Med. 2013. PMID: 23758730 Free PMC article.

6

Role of JNK Activation and Mitochondrial Bax Translocation in Allicin-Induced Apoptosis in Human Ovarian Cancer SKOV3 Cells.

Xu L, Yu J, Zhai D, Zhang D, Shen W, Bai L, Cai Z, Yu C. Xu L, et al. Evid Based Complement Alternat Med. 2014;2014:378684. doi: 10.1155/2014/378684. Epub 2014 Jul 8. Evid Based Complement Alternat Med. 2014. PMID: 25097657 Free PMC article.

7

Epigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity.

Lu J, Zhang X, Shen T, Ma C, Wu J, Kong H, Tian J, Shao Z, Zhao X, Xu L. Lu J, et al. Among authors: xu l. Evid Based Complement Alternat Med. 2016;2016:7276161. doi: 10.1155/2016/7276161. Epub 2016 Mar 20. Evid Based Complement Alternat Med. 2016. PMID: 27087825 Free PMC article.

8

Jin Fu Kang Oral Liquid Inhibits Lymphatic Endothelial Cells Formation and Migration.

He HL, Wang D, Tang J, Zhou XM, Li JX, Xu L. He HL, et al. Among authors: xu l. Evid Based Complement Alternat Med. 2016;2016:3635209. doi: 10.1155/2016/3635209. Epub 2016 Sep 6. Evid Based Complement Alternat Med. 2016. PMID: 27698675 Free PMC article.

9

Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation.

Ding R, Jiao L, Sang S, Yin Y, Wang Y, Gong Y, Xu L, Bi L. Ding R, et al. Among authors: xu l. Evid Based Complement Alternat Med. 2021 Dec 13;2021:9930082. doi: 10.1155/2021/9930082. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34938346 Free PMC article.

10

[Traditional Chinese medicine for cancer pain].

Wang JY, Xu L, Zhang RX, Lao L. Wang JY, et al. Among authors: xu l. Zhong Xi Yi Jie He Xue Bao. 2011 Feb;9(2):129-34. doi: 10.3736/jcim20110202. Zhong Xi Yi Jie He Xue Bao. 2011. PMID: 21288445 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,091 results

Search Page

Filters